Search results
Results From The WOW.Com Content Network
GXS (OpenText GXS) is a subsidiary of OpenText Corporation headquartered in Gaithersburg, Maryland, United States. [2] Its GXS Trading Grid managed more than twelve billion transactions [clarification needed] in 2011.
John of Châtillon (died 6 July 1298) was a canon of the Order of Val des Écoliers and a regent master of theology at the University of Paris. [ 1 ] John was a canon at the convent of Sainte-Catherine [ fr ] by 1288, when he attended the inventorying of the convent's library.
Nicholas Bernard Mangione (/ ˌ m æ n dʒ i ˈ oʊ n i / ⓘ MAN-jee-OH-nee, [1] Italian: [manˈdʒoːne]; [2] February 17, 1925 – November 2, 2008) was an American real estate developer.
When Clagett died in 1777, several sections of this property passed to his son, Joseph. The Tschiffely family began to farm the land in 1852, when Frederick A. Tschiffely, who owned a prominent wholesale pharmaceutical business in Washington, D.C., purchased more than 200 acres (0.81 km 2 ) of land from the Clagett heirs.
It then shifted to a decentralized model with separate groups meeting in College Park, Gaithersburg, Silver Spring, and Wheaton. In the mid-'80s the groups consolidated as Covenant Life Church and met together at Magruder High School. In September 1993 the church opened its new facility on a 45-acre campus located at 7501 Muncaster Mill Road.
Grable & Sons Metal Products, Inc. v. Darue Engineering & Mfg., 545 U.S. 308 (2005), was a United States Supreme Court decision [1] involving the jurisdiction of the federal district courts under 28 U.S.C. § 1331 (federal question jurisdiction).
Retrieved from "https://en.wikipedia.org/w/index.php?title=John_Wiley_%26_Sons,_Inc.&oldid=873099342"
Molecular Vaccines, Inc. was founded by Wayne T. Hockmeyer, David Mott, and Dr. James Young in 1988. [6] In 1989, Molecular Vaccines, Inc changed its name to MedImmune, Inc. On April 23, 2007, it was announced MedImmune and AstraZeneca entered into a definitive agreement under which AstraZeneca intended to acquire MedImmune in an all-cash ...